Xtl Biopharma ADR (XTLB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2009 | 12-2008 | 12-2007 | 12-2006 | 12-2005 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 2,580 | -9,240 | -24,930 | -15,130 | -14,010 |
| Depreciation Amortization | 10 | 30 | 100 | 240 | 240 |
| Other Working Capital | -590 | -1,430 | -290 | 330 | -1,260 |
| Other Operating Activity | -4,480 | 70 | 3,670 | 1,980 | 4,570 |
| Operating Cash Flow | $-2,480 | $-10,570 | $-21,450 | $-12,580 | $-10,460 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | 320 | 240 | 80 | -10 |
| Other Investing Activity | -20 | 10,590 | 10,390 | -20,910 | 9,530 |
| Investing Cash Flow | $-20 | $10,910 | $10,630 | $-20,830 | $9,520 |
| Cash Flows From Financing Activities | |||||
| Other Financing Activity | 0 | 210 | 8,790 | 24,460 | 1,510 |
| Financing Cash Flow | $0 | $210 | $8,790 | $24,460 | $1,510 |
| Beginning Cash Position | 2,920 | 2,370 | 4,400 | 13,360 | 12,780 |
| End Cash Position | 410 | 2,920 | 2,370 | 4,400 | 13,360 |
| Net Cash Flow | $-2,510 | $540 | $-2,020 | $-8,960 | $570 |
| Free Cash Flow | |||||
| Operating Cash Flow | -2,480 | -10,570 | -21,450 | -12,580 | -10,460 |
| Free Cash Flow | -2,480 | -10,570 | -21,450 | -12,580 | -10,460 |